Circulating tumor cells: silent predictors of metastasis

Circulating tumor cells (CTCs) were added to the arsenal of clinical testing in 2004 for three cancer types: metastatic breast, prostate, and colorectal cancer. CTCs were found to be an independent prognostic indicator of survival for these three diseases. Multiple enrichment/isolation strategies ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, LanLan, Dicker, David T., Matthew, Elizabeth, El-Deiry, Wafik S., Alpaugh, R. Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558099/
https://www.ncbi.nlm.nih.gov/pubmed/28868131
http://dx.doi.org/10.12688/f1000research.11313.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558099/
https://www.ncbi.nlm.nih.gov/pubmed/28868131
http://dx.doi.org/10.12688/f1000research.11313.1

Ejemplares similares